InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.42
(
0.72%
)
Bitcoin
64,431.59
(
1.27%
)
Post# of 253175
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: Whalatane post# 214463

Friday, 10/20/2017 3:16:49 PM

Friday, October 20, 2017 3:16:49 PM

Post# of 253175
ABEO:

At the R&D Day the MPS presenter said they would be enrolling the MPS IIIB study next week I believe and today there is a clinicaltrials entry.

https://clinicaltrials.gov/ct2/show/NCT03315182

BMRN's MPS IIIB program has initial very impressive biomarker data and initial signs of neurocognitive benefit. Still the route/frequency of administration is not without its challenges. I know payers wouldn't like it but hopefully the two could work synergistically one day and give these kids a better life!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up